News for Abbott Laboratories (ABTCL.SN)

Published at

Jul 11, 2025 3:37 AM

by gurufocus.com

positive

positive

Vanguard Group Inc. Expands Stake in AbbVie Inc. with Strategic Share Acquisition

On June 30, 2025, Vanguard Group Inc. made a significant move by acquiring an additional 3,348,838 shares of AbbVie Inc. (NYSE: ABBV) at a price of $185.62 per

MSFTD.BA MSFTCL.SN MSFTC.BA MSFTB.BA MSFT.MI APC.DE AMZNCL.SN AMZN.SN AMZN.MX AMZN AMZ.DE ABTCL.SN ABT.SN ABT ABBV34.SA ABBV.MX ABBV.BA ABBV AAPLD.BA AAPLCL.SN AAPLC.BA AAPL.SN AAPL.NE AAPL.MX AAPL.BA AAPL 4AB.DE

Read more →
Published at

Jul 10, 2025 4:00 PM

by gurufocus.com

mixed

mixed

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc (”Reckitt

ABTCL.SN ABT.SN ABT RKT.L RBN.MX RBGPF RBGLY RB.L 3RB.DE

Read more →
Published at

Jul 9, 2025 11:00 PM

by gurufocus.com

positive

positive

Abbott (ABT) Price Target Raised by Citi Analyst Ahead of Q2 Earnings | ABT Stock News

Citi's analyst, Joanne Wuensch, has increased the price target for Abbott (ABT) from $155 to $157 while maintaining a Buy rating on the company's shares. This a

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 9, 2025 3:09 PM

by insidermonkey.com

neutral

neutral

Oppenheimer Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 9, 2025 3:09 PM

by finance.yahoo.com

positive

positive

Oppenheimer Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at Oppenheimer reiterated an ‘Outperform’ rating on the stock and a $14 price target. The bullish stance follows the Centers for Medicare & Medicaid Services (CMS) final decision on transcatheter edge-to-edge repair for the […]

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 9, 2025 12:30 PM

by forbes.com

mixed

mixed

Should You Buy Abbott Stock At $135?

Is ABT stock still a good investment? We contend that it is.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 8, 2025 4:46 PM

by forexlive.com

positive

positive

mixed signals: Tech and healthcare rise while financials struggle

Get the latest stock market news: Stock movers, top-performing sectors, and popular stock activity. Stay ahead with a quick and comprehensive market rundown.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 8, 2025 4:03 PM

by benzinga.com

positive

positive

Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

DHR ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 7, 2025 10:00 PM

by gurufocus.com

mixed

mixed

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY

PR NewswireNEW YORK, July 7, 2025 NEW YORK, July 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt

ABTCL.SN ABT.SN ABT RKT.L RBN.MX RBGPF RBGLY RB.L 3RB.DE

Read more →
Published at

Jul 7, 2025 3:20 PM

by gurufocus.com

mixed

mixed

Absci Appoints Biopharma Leader Mary Szela to Board of Directors | ABSI Stock News

Absci (ABSI) appoints veteran biopharma executive Mary Szela to its Board of Directors. Two key pipeline programs underway: ABS-101 (Phase 1 expected in 202

ABTCL.SN ABT.SN ABT ABSI

Read more →
Published at

Jul 2, 2025 6:00 PM

by gurufocus.com

mixed

mixed

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY

PR NewswireNEW YORK, July 2, 2025 NEW YORK, July 2, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt

ABTCL.SN ABT.SN ABT RKT.L RBN.MX RBGPF RBGLY RB.L 3RB.DE

Read more →
Published at

Jul 2, 2025 4:46 PM

by forexlive.com

positive

positive

Tesla surges amid mixed tech sector performance as healthcare stocks climb

Get the latest stock market news: Stock movers, top-performing sectors, and popular stock activity. Stay ahead with a quick and comprehensive market rundown.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 2, 2025 3:00 PM

by zacks.com

neutral

neutral

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jul 1, 2025 3:00 PM

by finance.yahoo.com

positive

positive

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

Policies associated with the MAHA movement could boost these two stocks significantly.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jun 30, 2025 12:22 PM

by finance.yahoo.com

positive

positive

What to Expect From Abbott Laboratories' Q2 2025 Earnings Report

Abbott is poised to release its second-quarter results next month, and analysts project a single-digit earnings growth.

ALR ABTCL.SN ABT.SN ABT

Read more →
Published at

Jun 30, 2025 8:19 AM

by seekingalpha.com

positive

positive

Abbott Laboratories Stock: FreeStyle Libre CGMs And EPD Business Driving Momentum

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before. Read why ABT stock is a Buy.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jun 28, 2025 10:28 PM

by cnbc.com

positive

positive

The record-breaking week in the stock market that could have gone very badly

Incredible as that was, this week could have easily went another way.

NVDA.MI NVDA MSCL.SN CSCO AVGOP AVGO ABTCL.SN ABT.SN ABT AAPL

Read more →
Published at

Jun 28, 2025 5:00 PM

by gurufocus.com

mixed

mixed

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY

NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc (”Reckitt

ABTCL.SN ABT.SN ABT RKT.L RBN.MX RBGPF RBGLY RB.L 3RB.DE

Read more →
Published at

Jun 28, 2025 7:27 AM

by insidermonkey.com

neutral

neutral

Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum

In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite challenging conditions driven by tariffs.

ABTCL.SN ABT.SN ABT

Read more →
Published at

Jun 28, 2025 7:27 AM

by finance.yahoo.com

positive

positive

Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum

Abbott Laboratories (NYSE:ABT) is one of the Best Dividend Stocks of 2025. In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite challenging conditions driven by tariffs. The company exceeded Wall Street expectations across its three key profitability metrics: earnings per share, adjusted gross margin, […]

ABTCL.SN ABT.SN ABT

Read more →